
President, Environmental Claims, The Sandner Group, HINZ CLAIM MANAGEMENT INC
Member of the Law Council
Martin Alpert is President, The Sandner Group-Environmental Claims (formerly known as Hinz Claim Management) Chicago, Illinois and a litigation consultant at his own firm. He focuses on analyzing APH, Mass Tort, M & A's, Emerging Regulations & Class Actions, involving fortune 500 & over 2,500 select companies. He worked at Cambridge Integrated as an International Claim Director & was Claim Director for GE Reinsurance, resolving emerging industry issues in the U.S & abroad: asbestos, lead paint, pollution, energy, drug exposure, mass tort & construction. Mr. Alpert has over 30 years experience in Trials, corporate governance, healthcare, ADR & the insurance-reinsurance industry. He is a member of ATLA, ITLA, IADC, ISBA, DRI, and the CPCU Society & was involved in the National Forum for Environmental & Toxic Tort Issues. Prior to GE, he lectured for NBI & presented seminars on trial evidence, strategy & discovery procedures. Mr. Alpert received his Accounting B.A. from Villanova University, his JD from John Marshall Law School & also has CPCU, ARM, ASLI, ARe & CPD. (This is me - Update Profile)
G+ is a community for professionals, academics and entrepreneurs to connect through online discussions and in-person meetings. You will continue to see G+ Insights (formerly GLG News) here as well as on the G+ website, where you can share and discuss the G+ Insights you read.
January 26, 2012
BP poised to enter legal labyrinth | www.ft.com
Will BP risk going to trial?
Asbestos: Billions yet to be Paid!
October 24, 2011
GAO Reports Shines Light on Secretive Asbestos Trusts | www.law.com
How much will actually be paid out for asbestos claims and when will it end?
Environmental Hazards: TVA Ash Spill
September 20, 2011
Trial starts on damage lawsuits in TVA Ash | www.google.com
Should Federal agencies be protected from liability claims?
Pharmaceutical Liability: None for generic Drug Manufacturers?
June 28, 2011
Supreme Court protects generic-drug makers from being sued for lack of warning | www.washingtonpost.com
Should generic name drugs be treated the same as the brand name drugs they are intended to simulate?
Mortgage Investments: Another Large Settlement based on Fraud!
June 23, 2011
Morgan Keegan paying $200m to settle fraud charges - nytimes.com | www.nytimes.com
Should Federal and State regulators push for criminal penalties on fraud charges?
| Study Group Name | No. Members |
|---|---|
| Online Advertising Experts | 639 |
| Medicare Experts | 570 |
| Online Advertising Experts (North America) | 472 |
| TL and LTL Services Experts | 442 |
| Network Security Experts | 247 |
Martin Alpert has not participated in any GLG Live Meetings.
View all GLG Live Meetings in Legal, Economic & Regulatory Affairs